ncRNA name
hsa-miR-363-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
CUL4A
Cancer name
Non-Small Cell Lung Cancer
Cancer site
Lung
Treatment type
Chemotherapy
Drug
Gemcitabine
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
The results indicated that decreased miR-363-3p expression enhanced gemcitabine resistance in NSCLC cells via regulation of CUL4A.
Tissue resource
tumor tissues and matched adjacent normal tissues were collected from non-small cell lung cancer patients
human lung epithelial cell lines BEAS-2B
human non-small cell lung cancer cell lines A549
human non-small cell lung cancer cell lines H23
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
the Yancheng City No.1 People's Hospital
American Type Culture Collection
Country
China
USA
Continent
Asia
North American